Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 25.10.2022KRKA, d.d., Novo mesto (KRK-2)08798Amlessa 4 mg/5 mg tablety (tbl 90x4 mg/5 mg (blis.OPA/Al/PVC/Al))31.10.2022O
 25.10.2022KRKA, d.d., Novo mesto (KRK-2)3492BArisppa 10 mg tablety (tbl 14x10 mg (blis.OPA/Al/PVC/Al))30.10.2022O
 25.10.2022KRKA, d.d., Novo mesto (KRK-2)76204Doreta 37,5 mg/325 mg filmom obalené tablety (tbl flm 90x37,5 mg/325 mg (blis.PVC/PVDC/Al-nepriehľ.))5.12.2022R
 25.10.2022Menarini International Operations Luxembourg S.A. (MNR)07226Dexadol 25 mg gro por (gro por 10x25 mg (vre. Al/PE))25.10.2022R
 25.10.2022HEATON k.s. (HTN-3)0696EAnau 100 mg filmom obalené tablety (tbl flm 98x100 mg (blis.PVC/PE/PVDC/Al-neperfor.))25.10.2022U
 25.10.2022HEATON k.s. (HTN-3)0693EAnau 100 mg filmom obalené tablety (tbl flm 28x100 mg (blis.PVC/PE/PVDC/Al-neperfor.))25.10.2022U
 25.10.2022Menarini International Operations Luxembourg S.A. (MNR)75656Nebilet HCTZ 5 mg/12,5 mg (tbl flm 28x 5 mg/12,5 mg (blis. PP/COC/PP-Al))25.10.2022O
 24.10.2022Pfizer Europe MA EEIG (PFI-BE-3)14817FRAGMIN 5000 IU (anti-Xa)/0,2 ml (sol inj 10x0,2 ml (striek.inj.napl.jednor.))1.11.2022R
 24.10.2022Pfizer Europe MA EEIG (PFI-BE-3)25313DIFLUCAN P.O.S. 10 mg/ml (plu por 1x24,4 g (fľ.HDPE+odm.lyžička alebo striekačka))24.10.2022O
 24.10.2022Pfizer Europe MA EEIG (PFI-BE-3)33732PROSTIN E2 tbl vag (tbl vag 4x3 mg (blis.PE/PE/Al))7.11.2022R
 24.10.2022Novo Nordisk A/S (NOO)41355Actrapid Penfill 100 medzinárodných jednotiek/ml injekčný roztok v náplni (sol inj 10x3 ml/300 IU (3,5 mg/ ml) (skl.náplň))20.10.2022O
 24.10.2022B.Braun Melsungen AG (BME)1351CNutriflex Omega special bez elektrolytov (emu inf 5x1875 ml (vak infúzny viackomorový))24.10.2022O
 24.10.2022Mylan IRE Healthcare Limited (MYR)25607EpiPen (sol inj 1x2 ml/0,3 mg (amp.inj.skl.))24.10.2022O
 24.10.2022B.Braun Melsungen AG (BME)80181Gentamicin B. Braun 3 mg/ml infúzny roztok (sol inf 20x80 ml/240 mg (fľ. LDPE))24.10.2022O
 21.10.2022Teva B.V. (TEV-NL-4)51647Valsartan Teva 160 mg (tbl flm 98x160 mg (blis.PVC/PE/PVDC/Al))24.10.2022O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)